Position in OGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,311,646
+$1,310,617 QoQ
Shares Held
96,872
+220063.6% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#133
of 626 holders
Holding Since
Jun 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Skandinaviska Enskilda Banken AB (publ) holds $44,173,730 across 2 Drug Manufacturers - General names. OGN ranks #2 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
226,042 | $42,862,084 | |
| 2 | OGN |
Organon & Co.
This page
|
96,872 | $1,311,646 |
All Filings in OGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,311,646 | 96,872 | Shares | Sole | 2026-08-10 | |
| 2022-09-30 | $1,029 | 44 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,476 | 103 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $3,596 | 103 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $3,714 | 122 | Shares | Other | 2022-02-10 | |
| 2021-09-30 | $5,311 | 162 | Shares | Other | 2021-11-10 | |
| 2021-06-30 | $2,575,851 | 85,124 | Shares | Other | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||